Clinical Trial Update: Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis [Phase 3]

View source ↗

Summary

Phase 3 long-term study of NPC-01 for dysmenorrhea associated with endometriosis has completed. Efficacy and safety results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Endometriosis

Drugs mentioned

• NPC-01

Snippet

Sponsor: Nobelpharma | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED | Results posted: 2014-06-13